Strides Pharma Science Ltd vs Glenmark Pharmaceuticals Ltd
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Both companies need to be compared on revenue growth quality, margin trajectory and management commentary.
Glenmark Pharmaceuticals Ltd show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Strides Pharma Science Ltd | Glenmark Pharmaceuticals Ltd |
|---|---|---|
| Current Price | ₹1,014.8 | ₹2,166.6 |
| Market Cap | ₹9,356.42 Cr. | ₹61,152.33 Cr. |
| Industry | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology |
| P/E Ratio | 16.15 | 19.6 |
| ROE (%) | 19.99 | 23.56 |
| Debt/Equity | 0.57 | 0.06 |
| Sales Growth 5Y (%) | 7.94 | 9.19 |
| Profit Growth 5Y (%) | 4.84 | -0.29 |
| Promoter Holding (%) | 29 | 46.65 |
| Revenue Rank | Rank 3 | Rank 3 |
| Margin Rank | Rank 3 | Rank 3 |
| Signal | — | — |
| Capex | No | Yes |
| Fundraise | No information | No |